| P50 | author | Anxo Vidal | Q56488572 |
| | Maria A Garcia | Q59698173 |
| | Carlos Felipe de la Cruz-Herrera | Q85839258 |
| | Mariano Esteban | Q30004051 |
| | Carmen Rivas | Q39833905 |
| P2093 | author name string | Manuel S Rodríguez | |
| | Laura Marcos-Villar | |
| | Michela Campagna | |
| | Valerie Lang | |
| | Sylvia Gutiérrez | |
| | Maite Baz-Martínez | |
| P2860 | cites work | The B56alpha regulatory subunit of protein phosphatase 2A is a target for regulation by double-stranded RNA-dependent protein kinase PKR | Q22254335 |
| | Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics | Q24304372 |
| | Phosphorylation of the NFAR proteins by the dsRNA-dependent protein kinase PKR constitutes a novel mechanism of translational regulation and cellular defense | Q24310584 |
| | PACT, a protein activator of the interferon-induced protein kinase, PKR. | Q24319677 |
| | PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control | Q24336050 |
| | Tyrosine phosphorylation acts as a molecular switch to full-scale activation of the eIF2alpha RNA-dependent protein kinase | Q24535918 |
| | The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification | Q43548130 |
| | PKR protection against intranasal vesicular stomatitis virus infection is mouse strain dependent | Q44864022 |
| | Mechanistic Link between PKR Dimerization, Autophosphorylation, and eIF2α Substrate Recognition | Q57236276 |
| | Mutations in the Double-stranded RNA-activated Protein Kinase Insert Region That Uncouple Catalysis from eIF2α Binding | Q58666362 |
| | The double-stranded RNA-dependent protein kinase is also activated by heparin | Q69397069 |
| | The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis | Q71613218 |
| | Double-stranded RNA-dependent protein kinase (PKR) is regulated by reovirus structural proteins | Q73617493 |
| | The N-terminus of PKR is responsible for the activation of the NF-kappaB signaling pathway by interacting with the IKK complex | Q83115967 |
| | Antiviral actions of interferons | Q24550676 |
| | Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action | Q24672548 |
| | Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1 | Q27637899 |
| | Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. | Q27863703 |
| | Sumoylation regulates diverse biological processes | Q27865196 |
| | SUMO: a history of modification | Q28243325 |
| | In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy | Q28253409 |
| | A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes | Q28271534 |
| | SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation | Q28282094 |
| | Protein modification by SUMO | Q29547919 |
| | The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus. | Q33811639 |
| | Quantitative SUMO-1 modification of a vaccinia virus protein is required for its specific localization and prevents its self-association | Q33841407 |
| | The interferon-inducible double-stranded RNA-activated protein kinase self-associates in vitro and in vivo | Q33965039 |
| | A Toll-like receptor-responsive kinase, protein kinase R, is inactivated in endotoxin tolerance through differential K63/K48 ubiquitination | Q34231758 |
| | Phosphorylation of initiation factor elF-2 and the control of reticulocyte protein synthesis | Q34236342 |
| | SIRT1 stabilizes PML promoting its sumoylation | Q35092583 |
| | Heparin activates PKR by inducing dimerization | Q35706998 |
| | Inhibition of PKR by RNA and DNA viruses | Q36480640 |
| | Activation of PKR: an open and shut case? | Q36695833 |
| | Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression | Q36869463 |
| | Sumoylation at the host-pathogen interface | Q38116514 |
| | The impact of PKR activation: from neurodegeneration to cancer. | Q38187546 |
| | Specific mutations near the amino terminus of double-stranded RNA-dependent protein kinase (PKR) differentially affect its double-stranded RNA binding and dimerization properties | Q38352344 |
| | SUMOylation of p53 mediates interferon activities | Q39106989 |
| | Activation of double-stranded RNA-activated protein kinase (PKR) by interferon-stimulated gene 15 (ISG15) modification down-regulates protein translation | Q39228289 |
| | Regulation of the tumor suppressor PTEN by SUMO. | Q39271041 |
| | Regulation of vaccinia virus E3 protein by small ubiquitin-like modifier proteins | Q39466076 |
| | Kaposi's sarcoma-associated herpesvirus protein LANA2 disrupts PML oncogenic domains and inhibits PML-mediated transcriptional repression of the survivin gene | Q39833667 |
| | Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection | Q40863327 |
| | Mutational analysis of the double-stranded RNA (dsRNA) binding domain of the dsRNA-activated protein kinase, PKR. | Q42830084 |
| P433 | issue | 38 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 26357-26367 | |
| P577 | publication date | 2014-07-29 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Activation of the double-stranded RNA-dependent protein kinase PKR by small ubiquitin-like modifier (SUMO) | |
| P478 | volume | 289 | |